Propanc Biopharma, Inc. (PPCB) Debt by Year
Propanc Biopharma, Inc. carried $538K in long-term debt against $12K in cash and equivalents at the end of fiscal year 2025. This represents an increase of 34.7% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Propanc Biopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PPCB Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25S-1 | FY24S-1 | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $538K+34.7% | $399K+2.2% | $391K-57.8% | $926K+48.3% | $625K-59.9% | $1.6M-6.0% | $1.7M-64.7% | $4.7M+35.0% | $3.5M+189.4% | $1.2M | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $12K-42.7% | $21K+109.9% | $10K+147.0% | $4K+80.4% | $2K-96.6% | $67K+2699.0% | $2K-88.0% | $20K-71.1% | $69K-43.0% | $121K+12.5% | $108K+22.6% | $88K | $0-100.0% | $179+35.6% | $132 |
PPCB Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'26S-1 | Q2'26S-1 | Q1'26S-1 | Q4'25S-1 | Q3'25S-1 | Q2'25S-1 | Q1'25S-1 | Q4'24S-1 | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $55K-87.5% | $55K-86.6% | $107K-72.0% | $538K+34.7% | $439K-24.8% | $410K-40.4% | $382K-3.9% | $399K+2.2% | $583K+12.2% | $688K | $397K-56.5% | $391K-57.8% |
| Cash & Equivalents | $444K+774.1% | $561K+3735.4% | $603K+6403.4% | $12K-42.7% | $51K+715.8% | $15K-79.6% | $9K+39.9% | $21K+109.9% | $6K-93.3% | $72K+192.7% | $7K-65.8% | $10K+147.0% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Propanc Biopharma, Inc. financials
Frequently Asked Questions
What was Propanc Biopharma, Inc.'s long-term debt in fiscal year 2025?
Propanc Biopharma, Inc. carried $538K in long-term debt against $12K in cash and equivalents at the end of fiscal year 2025.
How fast is Propanc Biopharma, Inc.'s long-term debt growing?
Propanc Biopharma, Inc. (PPCB) long-term debt rose by 34.7% year over year, from $399K to $538K in fiscal year 2025.
What was Propanc Biopharma, Inc.'s long-term debt in the most recent quarter?
Propanc Biopharma, Inc. (PPCB) reported $55K in long-term debt in Q3 2026. This represents a decrease of 87.5% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Propanc Biopharma, Inc. (PPCB) reported on that line in every period on record.